In populations with CKD with and without haemodialysis, BNP and CRP are regarded as risk markers for cardiovascular disease and CKD progression [30], and patients who present with inflammation and OH are at an increased risk of all-cause mortality compared with those without measurable signs of inflammation and OH [31]. This evidence concerns the gene CRP and chronic kidney disease.